scholarly journals Antitumor and Antimetastatic Activities of Docetaxel Are Enhanced by Genistein through Regulation of Osteoprotegerin/Receptor Activator of Nuclear Factor-κB (RANK)/RANK Ligand/MMP-9 Signaling in Prostate Cancer

2006 ◽  
Vol 66 (9) ◽  
pp. 4816-4825 ◽  
Author(s):  
Yiwei Li ◽  
Omer Kucuk ◽  
Maha Hussain ◽  
Judith Abrams ◽  
Michael L. Cher ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Nuclear Factor Κb ◽  
Nuclear Factor ◽  
Rank Ligand ◽  
Receptor Activator

scholarly journals Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women

2018 ◽  
Vol 11 (12) ◽  
pp. 789-796 ◽  
Author(s):  
Adetunji T. Toriola ◽  
Catherine M. Appleton ◽  
Xiaoyu Zong ◽  
Jingqin Luo ◽  
Katherine Weilbaecher ◽  
...  
Keyword(s):  
Mammographic Density ◽  
Premenopausal Women ◽  
Nuclear Factor Κb ◽  
Nuclear Factor ◽  
Rank Ligand ◽  
Receptor Activator

scholarly journals Toxicities Following Treatment with Bisphosphonates and Receptor Activator of Nuclear Factor-κB Ligand Inhibitors in Patients with Advanced Prostate Cancer

2014 ◽  
Vol 65 (2) ◽  
pp. 278-286 ◽  
Author(s):  
Benjamin A. Gartrell ◽  
Robert E. Coleman ◽  
Karim Fizazi ◽  
Kurt Miller ◽  
Fred Saad ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Advanced Prostate Cancer ◽  
Nuclear Factor Κb ◽  
Nuclear Factor ◽  
Receptor Activator
Sign in / Sign up

Export Citation Format

Share Document